IVM
InterWest Venture Management Portfolio holdings
AUM
$20.6M
This Quarter Return
-50.77%
1 Year Return
+48.5%
3 Year Return
-59.65%
5 Year Return
-75.84%
10 Year Return
–
AUM
$94.7M
AUM Growth
+$94.7M
(-59%)
Cap. Flow
-$10.9M
Cap. Flow
% of AUM
-11.48%
Top 10 Holdings %
Top 10 Hldgs %
99.86%
Holding
12
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
The RealReal
REAL
|
$10.9M |
Sector Composition
| 1 | Healthcare | 61.84% |
| 2 | Consumer Discretionary | 38.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
The RealReal
REAL
$879M
| $36.1M | 38.17% |
5,154,080
-1,550,000
| -23% | -$10.9M |
|
2
Glaukos
GKOS
$5.5B
| $31.3M | 33.03% |
1,013,364
| – | – |
|
3
MacroGenics
MGNX
$112M
| $6.25M | 6.61% |
1,074,316
| – | – |
|
|
EIGR
4
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $5.2M | 5.49% |
764,918
| – | – |
|
|
AGTC
5
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $4.78M | 5.05% |
1,455,904
| – | – |
|
6
Cidara Therapeutics
CDTX
$1.66B
| $3.37M | 3.55% |
1,356,813
| – | – |
|
7
KalVista Pharmaceuticals
KALV
$678M
| $2.97M | 3.14% |
388,766
| – | – |
|
8
Venus Concept
VERO
$4.11M
| $2.34M | 2.47% |
658,657
| – | – |
|
9
Neuronetics
STIM
$220M
| $1.95M | 2.06% |
1,030,689
| – | – |
|
|
HIND
10
Vyome Holdings, Inc. Common Stock
HIND
$243M
| $274K | 0.29% |
380,224
| – | – |
|
11
Xenon Pharmaceuticals
XENE
$2.98B
| $94K | 0.1% |
8,293
| – | – |
|
12
Dare Bioscience
DARE
$27.2M
| $43K | 0.05% |
50,368
| – | – |
|